Sinovac Biotech Co., Ltd: all 163 studies

Page 2 of 2. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years OldCompletedNCT04997239Phase 4
• Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)CompletedNCT04993365Phase 4
• Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and AdolescentsCompletedNCT04992260Phase 3
• Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and AdolescentsCompletedNCT04992208Phase 4
• A Clinical Trial of 23-valent Pneumococcal Polysaccharide VaccineCompletedNCT04989465Phase 4
• An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four DosesCompletedNCT04989231
• Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican RepublicCompletedNCT04974164
• Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy AdultsStatus unknownNCT04962308Phase 4
• Immunogenicity and Safety of an Inactivated COVID-19 VaccineCompletedNCT04953325Phase 4
• Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in AdultsCompletedNCT04911790Phase 4
• Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy AdultsCompletedNCT04894227Phase 4
• Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and AdolescentsCompletedNCT04884685Phase 2
• Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza VaccineCompletedNCT04801888Phase 4
• Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine ImmunizationCompletedNCT04618783Not applicable
• Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in AdultsCompletedNCT04617483Phase 3
• Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19CompletedNCT04551547Phase 1/2
• Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio VaccineCompletedNCT04386707Phase 3
• Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)CompletedNCT04383574Phase 1/2
• Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps VaccineCompletedNCT04364399Phase 4
• Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)CompletedNCT04352608Phase 1/2
• Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization VaccinesCompletedNCT04111432Phase 4
• Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)CompletedNCT04075201Phase 1
• Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 MonthsCompletedNCT03909074Phase 3
• Efficacy Trial of a Commercial EV71 VaccineCompletedNCT03903926Phase 4
• Immunogenicity and Safety of Two Different Commercial EV71 VaccinesCompletedNCT03873740Phase 4
• Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)CompletedNCT03859141Phase 3
• Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)CompletedNCT03853993Phase 3
• A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in InfantsCompletedNCT03822767Phase 3
• A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in InfantsCompletedNCT03822754Phase 3
• A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella VaccineCompletedNCT03555071Phase 3
• An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old InfantsCompletedNCT03526978Phase 3
• Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT03281174
• Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedNCT03278132Phase 4
• Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI VaccinesCompletedNCT03274102Phase 4
• Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus VaccineCompletedNCT02985320Phase 1/2
• A Blind, Randomized and Controlled Study of Live Attenuated Varicella VaccinesCompletedNCT02981836Phase 3
• A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and ChildrenCompletedNCT02965404Phase 1
• Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy InfantsCompletedNCT02692599Phase 3
• Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and ElderlyCompletedNCT02451969Phase 3
• Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B VaccineCompletedNCT02445703Phase 4
• The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza VaccineCompletedNCT02269852Phase 4
• The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy ChildrenCompletedNCT02002065
• A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT02001233
• Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young AdultsCompletedNCT01865968Phase 4
• Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in InfantsWithdrawnNCT01812135Phase 2
• The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza VaccineCompletedNCT01736709Phase 4
• Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01636245Phase 3
• An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01507857Phase 3
• Safety and Immunogenicity of an Inactivated EV71 Vaccine in InfantsCompletedNCT01421121Phase 2
• Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedNCT01273246Phase 1
• Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy AdultsCompletedNCT01273233Phase 1
• Immunogenicity and Interchangeability of Two Inactivated Hepatitis A VaccinesCompletedNCT01252680Phase 4
• Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months InfantsCompletedNCT01047202Phase 4
• Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, AdultsCompletedNCT01008137Phase 4
• A Clinical Trial of Split-virion Influenza A/H1N1 VaccinesCompletedNCT01004653Phase 4
• A Clinical Trial With Influenza A/H1N1 VaccinesCompletedNCT00956111Phase 4
• Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in ChildrenCompletedNCT00900991Phase 2
• Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in AdolescentsCompletedNCT00900588Phase 2
• Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)VaccineCompletedNCT00660257Phase 1
• Phase IV Clinical Trial of an Influenza Split Vaccine AnfluCompletedNCT00556062Phase 4
• Safety and Immunogenicity of an Inactivated Pandemic Influenza VaccineCompletedNCT00535665Phase 2
• Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A VaccineCompletedNCT00534885Phase 4
• Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy SubjectsCompletedNCT00356798Phase 1

← Sinovac Biotech Co., Ltd overview and focus areas